Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 28 Jan 2025 for Eloxx Pharmaceuticals, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Sumit Aggarwal: trading record in brief
Sumit Aggarwal is a declared insider of Eloxx Pharmaceuticals, Inc. (chief executive), with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 1 December 2021 and the latest from 24 January 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 28 January 2025 with an option exercise in Eloxx Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Sumit Aggarwal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
30,000 shares0Common StockSEC:0001104659-25-006784:0
165,000 shares0Common StockSEC:0001104659-24-109519:0
279,158 shares0Common StockSEC:0001415889-21-005693:0
3 of 3 declarations
